‘Mylan must be held accountable’: why a generic EpiPen could prevent a cheaper product in the long term

August 29, 2016 5:16 PM

20 0

‘Mylan must be held accountable’: why a generic EpiPen could prevent a cheaper product in the long term

A cheaper product costs the company less than public fury, says one analyst

After an outcry over the price of its allergic reaction treatment EpiPen, Mylan Inc. said Monday that it would soon offer an identical generic product at less than half the cost.

Also read: Chicken Deal Expands Pilgrim's Pride Products, Territory

Read more

To category page

Loading...